Literature DB >> 26961877

O-Glycosylation of a Secretory Granule Membrane Enzyme Is Essential for Its Endocytic Trafficking.

Kurutihalli S Vishwanatha1, Nils Bäck2, TuKiet T Lam3, Richard E Mains4, Betty A Eipper5.   

Abstract

Peptidylglycine α-amidating monooxygenase (PAM) (EC 1.14.17.3) catalyzes peptide amidation, a crucial post-translational modification, through the sequential actions of its monooxygenase (peptidylglycine α-hydroxylating monooxygenase) and lyase (peptidyl-α-hydroxyglycine α-amidating lyase (PAL)) domains. Alternative splicing generates two different regions that connect the protease-resistant catalytic domains. Inclusion of exon 16 introduces a pair of Lys residues, providing a site for controlled endoproteolytic cleavage of PAM and the separation of soluble peptidylglycine α-hydroxylating monooxygenase from membrane-associated PAL. Exon 16 also includes two O-glycosylation sites. PAM-1 lacking both glycosylation sites (PAM-1/OSX; where OSX is O-glycan-depleted mutant of PAM-1) was stably expressed in AtT-20 corticotrope tumor cells. In PAM-1/OSX, a cleavage site for furin-like convertases was exposed, generating a shorter form of membrane-associated PAL. The endocytic trafficking of PAM-1/OSX differed dramatically from that of PAM-1. A soluble fragment of the cytosolic domain of PAM-1 was produced in the endocytic pathway and entered the nucleus; very little soluble fragment of the cytosolic domain was produced from PAM-1/OSX. Internalized PAM-1/OSX was rapidly degraded; unlike PAM-1, very little internalized PAM-1/OSX was detected in multivesicular bodies. Blue native PAGE analysis identified high molecular weight complexes containing PAM-1; the ability of PAM-1/OSX to form similar complexes was markedly diminished. By promoting the formation of high molecular weight complexes, O-glycans may facilitate the recycling of PAM-1 through the endocytic compartment.
© 2016 by The American Society for Biochemistry and Molecular Biology, Inc.

Entities:  

Keywords:  AtT-20 cell; electron microscopy (EM); furin; lysosome; multivesicular body; neuropeptide; protein secretion

Mesh:

Substances:

Year:  2016        PMID: 26961877      PMCID: PMC4850319          DOI: 10.1074/jbc.M115.711838

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  65 in total

1.  Lysosomal and proteasomal degradation play distinct roles in the life cycle of Cx43 in gap junctional intercellular communication-deficient and -competent breast tumor cells.

Authors:  Hong Qin; Qing Shao; Suleiman A Igdoura; Moulay A Alaoui-Jamali; Dale W Laird
Journal:  J Biol Chem       Date:  2003-05-26       Impact factor: 5.157

2.  Database analysis of O-glycosylation sites in proteins.

Authors:  T H Thanka Christlet; K Veluraja
Journal:  Biophys J       Date:  2001-02       Impact factor: 4.033

Review 3.  A genetic approach to Mammalian glycan function.

Authors:  John B Lowe; Jamey D Marth
Journal:  Annu Rev Biochem       Date:  2003-03-27       Impact factor: 23.643

4.  Protein glycosylation: chaperone mutation in Tn syndrome.

Authors:  Tongzhong Ju; Richard D Cummings
Journal:  Nature       Date:  2005-10-27       Impact factor: 49.962

Review 5.  Dynamic interplay between O-glycosylation and O-phosphorylation of nucleocytoplasmic proteins: a new paradigm for metabolic control of signal transduction and transcription.

Authors:  Kazuo Kamemura; Gerald W Hart
Journal:  Prog Nucleic Acid Res Mol Biol       Date:  2003

6.  Mutations in GALNT3, encoding a protein involved in O-linked glycosylation, cause familial tumoral calcinosis.

Authors:  Orit Topaz; Daniel L Shurman; Reuven Bergman; Margarita Indelman; Paulina Ratajczak; Mordechai Mizrachi; Ziad Khamaysi; Doron Behar; Dan Petronius; Vered Friedman; Israel Zelikovic; Sharon Raimer; Arieh Metzker; Gabriele Richard; Eli Sprecher
Journal:  Nat Genet       Date:  2004-05-09       Impact factor: 38.330

7.  Essential features of the catalytic core of peptidyl-alpha-hydroxyglycine alpha-amidating lyase.

Authors:  Aparna S Kolhekar; Joseph Bell; Eric N Shiozaki; Lixian Jin; Henry T Keutmann; Tracey A Hand; Richard E Mains; Betty A Eipper
Journal:  Biochemistry       Date:  2002-10-15       Impact factor: 3.162

Review 8.  Advances in mass spectrometry driven O-glycoproteomics.

Authors:  Steven B Levery; Catharina Steentoft; Adnan Halim; Yoshiki Narimatsu; Henrik Clausen; Sergey Y Vakhrushev
Journal:  Biochim Biophys Acta       Date:  2014-10-02

9.  The crystal structure of the proprotein processing proteinase furin explains its stringent specificity.

Authors:  Stefan Henrich; Angus Cameron; Gleb P Bourenkov; Reiner Kiefersauer; Robert Huber; Iris Lindberg; Wolfram Bode; Manuel E Than
Journal:  Nat Struct Biol       Date:  2003-07

10.  Ubiquitination and proteasomal activity is required for transport of the EGF receptor to inner membranes of multivesicular bodies.

Authors:  Karianne E Longva; Froydis D Blystad; Espen Stang; Astrid M Larsen; Lene E Johannessen; Inger H Madshus
Journal:  J Cell Biol       Date:  2002-02-25       Impact factor: 10.539

View more
  4 in total

1.  A pH-sensitive luminal His-cluster promotes interaction of PAM with V-ATPase along the secretory and endocytic pathways of peptidergic cells.

Authors:  Vishwanatha K Rao; Gerardo Zavala; Abhijit Deb Roy; Richard E Mains; Betty A Eipper
Journal:  J Cell Physiol       Date:  2018-10-14       Impact factor: 6.384

2.  Identifying roles for peptidergic signaling in mice.

Authors:  Kathryn G Powers; Xin-Ming Ma; Betty A Eipper; Richard E Mains
Journal:  Proc Natl Acad Sci U S A       Date:  2019-08-27       Impact factor: 11.205

3.  Changes in Corticotrope Gene Expression Upon Increased Expression of Peptidylglycine α-Amidating Monooxygenase.

Authors:  Richard E Mains; Crysten Blaby-Haas; Bruce A Rheaume; Betty A Eipper
Journal:  Endocrinology       Date:  2018-07-01       Impact factor: 4.736

Review 4.  Peptidylglycine α-amidating monooxygenase as a therapeutic target or biomarker for human diseases.

Authors:  David J Merkler; Aidan J Hawley; Betty A Eipper; Richard E Mains
Journal:  Br J Pharmacol       Date:  2022-02-28       Impact factor: 9.473

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.